Recent Progress in Development of Polo-Like Kinase 1 Inhibitors: Efforts So Far
Polo-like kinase 1(Plk1) plays an important role in the inhibition of cell proliferation and which is come under the family of serine/threonine-protein kinase. Which is a highly specific target for cancer therapy. In some clinical studies, Plk1 has been identified as a target for cancer. Currently,...
Guardado en:
Autores principales: | Ramesh L. Sawant, Jyoti B. Wadekar, Rushikesh D. Ukirde, Ganesh D. Barkade |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Tabriz University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0a9f7fde490847278b7fe11ff030ad94 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Overcoming PLK1 inhibitor resistance by targeting mevalonate pathway to impair AXL-TWIST axis in colorectal cancer
por: Sonia Solanes-Casado, et al.
Publicado: (2021) -
Silybum marianum seed disrupts mitosis by reducing polo-like kinase 1 in breast cancer cells
por: Hsing-Yu Jao, et al.
Publicado: (2022) -
Polo-like kinase 1 inhibition in NSCLC: mechanism of action and emerging predictive biomarkers
por: Stratmann JA, et al.
Publicado: (2019) -
Differences in Body Composition between Water Polo Players of National Teams of Montenegro and Croatia Participating in the European U15 Championship 2019
por: Gardasevic,Jovan, et al.
Publicado: (2020) -
Differences in Body Composition between Water Polo Players (U18) of the Southeast Europe Top Clubs
por: Gardasevic,Jovan, et al.
Publicado: (2021)